The framework agreement will be executed by issuing purchase orders. Each lot will be the subject of a separate allocation.
Multipurpose human immunoglobulin for extravascular administration — 200 mg/mlMultipurpose immunoglobulins of human origin for extravascular administration — 200 mg/ml.
Multipurpose human immunoglobulin for extravascular administration — 165 mg/mlMultipurpose human immunoglobulin for extravascular administration — 165 mg/ml.
Multipurpose human-made immunoglobulins — all assaysMultipurpose immunoglobulins of human origin — all dosages.
Multipurpose human immunoglobulins for intravenous administration — 5%Multipurpose immunoglobulins of human origin for intravenous administration — 5%.
Multipurpose human immunoglobulin for intravenous administration — 10%Multipurpose immunoglobulins of human origin for intravenous administration — 10%.
Crizanlizumab dilute solution for infusionCrizanlizumab dilute solution for infusion.
Wipes or compresses impregnated with aqueous chlorhexidine 2%Wipes or compresses impregnated with aqueous chlorhexidine 2%.